Evidence map›Paper›PMID 36399574›Full record

ArticleScience advances2022

Spatially targeted brain cancer immunotherapy with closed-loop controlled focused ultrasound and immune checkpoint blockade.

Hohyun Lee, Yutong Guo, James L Ross, Scott Schoen, F Levent Degertekin, Costas Arvanitis

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Hohyun LeeG.W. School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID 0000-0002-7939-6751
Yutong GuoG.W. School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID 0000-0002-3712-8353
James L RossDepartment of Microbiology and Immunology, Emory University, Atlanta, GA, USA.
Scott SchoenHarvard Medical School and Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-7195-2883
F Levent DegertekinG.W. School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID 0000-0001-9198-8525
Costas ArvanitisG.W. School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID 0000-0002-7737-1446
Georgia Institute of Technology · USEmory University · USHarvard University · US

Funding

"Transcranial FUS therapy with closed-loop US image guidance and circulating tumor DNAR37CA239039 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI Konstantinos-Costas Arvanitis · 2020 to 2026
$3.3M
NCI NIH HHS R37 CA239039
6 · The paper itself

Abstract

Despite the challenges in treating glioblastomas (GBMs) with immune adjuvants, increasing evidence suggests that targeting the immune cells within the tumor microenvironment (TME) can lead to improved responses. Here, we present a closed-loop controlled, microbubble-enhanced focused ultrasound (MB-FUS) system and test its abilities to safely and effectively treat GBMs using immune checkpoint blockade. The proposed system can fine-tune the exposure settings to promote MB acoustic emission-dependent expression of the proinflammatory marker ICAM-1 and delivery of anti-PD1 in a mouse model of GBM. In addition to enhanced interaction of proinflammatory macrophages within the PD1-expressing TME and significant improvement in survival (

Indexed as

Brain NeoplasmsGlioblastomaAnimalsBrainImmune Checkpoint InhibitorsImmunologic FactorsImmunotherapyMiceTumor MicroenvironmentImmune Checkpoint InhibitorsImmunologic Factors

Identifiers

PMID36399574
PMCPMC9674274
OpenAlexW4309469576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.